# Risk: __Lack of Effective Treatment__ (PBN__Risk_1868)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [research and development of vaccines](../Technology/PBN__Technology_1237)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [individuals infected with covid-19](../Stakeholder/PBN__Stakeholder_686)

## Property: has_RiskType

* [health](../RiskType/PBN__RiskType_4)
* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [pharmaceutical companies](../Stakeholder/PBN__Stakeholder_124)
* [research institutions](../Stakeholder/PBN__Stakeholder_413)

## Property: has_RiskMitigation

* [Support ongoing research for vaccine development and antiviral medications, repurpose existing drugs for treatment](../RiskMitigation/PBN__RiskMitigation_2457)

## Property: has_RiskName

Increased severity and mortality rates

## Property: has_RiskDescription

There are no specific medicines or vaccines available to control or treat COVID-19.

## Property: has_RiskSource

* [paital_nurture_2020](../Article/PBN__Article_44)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

